International Clinical Trial: The efficacy and safety of olanzapine combined with osimertinib in the treatment of locally advanced or metastatic non-small cell lung cancer with EGFR exon 21 L858R mutation: A single-arm, prospective, multicenter clinical study

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114640) titled 'The efficacy and safety of olanzapine combined with osimertinib in the treatment of locally advanced or metastatic non-small cell lung cancer with EGFR exon 21 L858R mutation: A single-arm, prospective, multicenter clinical study' on Dec. 16, 2025.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: China-Japan Friendship Hospital

Condition: EGFR exon 21 L858R mutation in locally advanced or metastatic non-small cell lung cancer

Recruitment Status: Not Recruiting

Phase: 4

Date of First Enrollment: 2026-01-01

Target Sample Size: experimental group:70;

Countries of Recruitment:...